The global tissue diagnostics market is growing at 8.6% CAGR during the forecasted years of 2016-2023. The tissue diagnostic technique is majorly used for detection of cancer, majorly due to its capability to detect cancer at an early stage, and is anticipated to witness a significant growth over the forecast year. Rising incidences of breast cancer, increasing geriatric population and the growing demand for personalized medicines are the major drivers of the global tissue diagnostics market. Apart from this, improving healthcare infrastructure, rising demand for safe and cost effective treatment and increasing focus of the major market players on emerging economies such as China and India are likely to drive the global tissue diagnostics market. Technological advancement in the field of tissue diagnostics is projected to provide better option for healthcare patients and professionals. Tissue diagnostic procedures encompass a broad selection of technologies designed to revolutionize the process of cancer diagnosis and provide apt molecular information. The tissue diagnostic detects the existence of malignant cells by performing microscopic study of the involved tissue. This examination is considered to be vital for detecting any type of cancer in order to decide the effective treatment line.
Rising trend of personalized medicines, increasing number of cancer patients, growing opportunities in digital pathology and high demand for molecular and companion diagnostics are the major factors boosting the global tissue diagnostics market. Limited customer base for tissue diagnostics, limited budget issues and stringent regulatory framework are the major factors which act as a barrier in the growth of the market.
The major drivers of the Tissue diagnostics Market Includes:
- Increase in the demand of personalized medicines.
- Enhancing number of cancer patients.
- Rise in Healthcare expenditure.
- Enhancement in In-Vitro diagnosis.
Hospital-based pathology laboratories majorly use tissue diagnostics for disease diagnosis, while many pharmaceutical companies also use them for drug discovery. Advances in technology are greatly affecting medical areas such as pathology laboratories, leading academic and research institutes, and medical research centres globally, which use tissue diagnostics for various medical purposes. The application of tissue diagnostics by these new consumers has become a turning point for the market in the forecast years.
But, the high cost of tissue diagnostics and reimbursement issues related to tissue diagnostics act as a hurdle and affects the growth of global tissue diagnostics market.
Global tissue diagnostics market is segmented into technology, disease, products, end users and regional outlook. By technology segment, market is divided into immunohistochemistry, in situ hybridization, digital pathology and workflow management, magneto encephalograph and special staining. Immunohistochemistry dominates the technology segment of global tissue diagnostics market, majorly due to rising incidences of cancer diagnostic. Digital pathology is growing at a faster pace. In disease segment, market is divided into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung carcinoma and other disease. Breast cancer diagnostic segment of disease segment, accounted for highest market share of the global tissue diagnostics market in 2015. Lifestyle associated changes, rising alcohol consumption, and growing geriatric population are some of the factors which are boosting the growth of global tissue diagnostics market. In product segment, market is divided into instrument and consumables. Instruments are having major applications in global tissue diagnostics market. In end user segment, market is divided into hospitals, pharmaceuticals, research laboratories, contract research organization and others. Hospitals have the maximum market share of end users segment, reason being increasing use of tissue diagnostics techniques in hospital.
Source-OBRC Analysis
The report scope is widely categorized on the basis of its segments which includes Technology, Disease, Products and End user. Technology is further sub segmented into:
- IMMUNOCHEMISTRY
- IN SITU HYBRIDIZATION
- DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT
- MAGNETOENCEPHALOGRAPH
- SPECIAL STAINING
Disease segment is further segmented into:
- BREAST CANCER
- GASTRIC CANCER
- LYMPHOMA
- PROSTATE CANCER
- NON-SMALL CELL LUNG CARCINOMA
- OTHER DISEASE
The Product segment is further sub-segmented into:
- INSTRUMENT MARKET
- CONSUMABLES MARKET
The End user segment is further sub-segmented into:
- HOSPITALS
- PHARMACEUTICALS
- RESEARCH LABORATORIES
- CONTRACT RESEARCH ORGNIZATIONS
- OTHERS
The revenue for the above end-user segments are specific to the tissue diagnostic market. However, the total revenue of these end-user in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up disease and product segment. Geographically, the global tissue diagnostics market has been segmented on the basis of four major region, which include:
- North America (U.S. & Canada)
- Asia Pacific (China, India, Japan, RoAPAC)
- Europe (UK, France, Germany, RoE)
- Rest of the World
In regional outlook, market is divided into North America, Europe, Asia Pacific and rest of the world. North America dominates the global tissue diagnostics market, accounting for around 40.7% of market share. The major reasons which are boosting the North American region upward are the rising patient’s awareness level, presence of technologically advanced products, and growing healthcare expenditures. The United States and Canada are the major countries in the North American region. Asia Pacific is the fastest growing region for global tissue diagnostics market. Rapid improvement in healthcare infrastructure, presence of sophisticated healthcare facilities in the developed markets of Australia and Japan boost the market growth. Asia Pacific is one of the most profitable and revenue generating market for major market players in the forecast period. China, Japan, South Korea and Australia are the major countries in Asia Pacific region that help in market growth. Europe is showing positive growth due to rising prevalence of cancer in this region, favourable government policies related to tissue diagnostics and increasing geriatric population. Rest of the world is showing positive growth rate for the global tissue diagnostics market in the forecast period. Brazil, Middle East are the countries in this Rest of the world region, that fuel the market.
The major market players of the global tissue diagnostic market are:
- ROCHE
- ABBOTT LABORATORIES
- BECTON DICKINSON & COMPANY
- MEDTRONIC INC
- STRYKER
- DANAHER CORPORATION
The Mergers & acquisition, Strategy and expansions are the key strategies which are adopted by the market players to develop and sustain in the market. ACD corporation has come up with partnership strategy with CST and Definiens to operate and expand in the European market.
Why to buy the report:
This report will provide you:
- Provide in detail the different segments such as by products and end-users which are affecting the global Tissue Diagnostics market.
- Provide you the patent analysis of the Tissue Diagnostics market.
- Identify, understand, and the strength, opportunities, challenges and threat of the Tissue Diagnostics market.
- Provide revenues of major players of the market such as Roche and Abbott Laboratories security systems.
- Provide you various the regulatory policies which are affecting the global Tissue Diagnostics market.
How we are different from others:
At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on Tissue diagnostics market offers the longest chain of market segmentation covering major market segmentation based on products and end users.The report tracks the major market trends in the global Tissue diagnostics market such as increase in healthcare expenditure and rise in demand of in in-vitro diagnosis. For each market segments covered in global Proteomics report, we provide opportunity matrix, and DRO analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the Tissue diagnostics industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360 degree analysis, See Saw analysis, and Porter five force model and so on. For the high level analysis in the report we provide a comparative analysis of historic and current year data.
Key Findings of the global tissue diagnostics market:
- North America is anticipated to generate the largest revenue share in 2016.
- Increasing government support.
- Partnership is the key strategy adopted by the various market players of tissue diagnostics market.
- Pharmaceuticals sector is the major segment of end user.
